Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.36 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.36 |
| ▸ | CPA1 | P15085 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2215432 | 0.86 | GRIK1 (0.33) | GRIK1GRIK2CPA1 | |
| SCHEMBL4282149 | 0.78 | GRIK1 (0.40) | GRIK1GRIK2CPA1 | |
| SCHEMBL11041786 | 0.77 | MMP2 (0.34) | CPA1 | |
| SCHEMBL9755825 | 0.77 | KMT2A (0.40) | GRIK1GRIK2CPA1 | |
| Hydrogen Sulfide SCHEMBL28215675 | 0.75 | GRIK1 (0.38) | GRIK1GRIK2CPA1 | |
| SCHEMBL11128669 | 0.75 | MEN1 (0.41) | GRIK1GRIK2CPA1 | |
| SCHEMBL28639365 | 0.75 | GRIK1 (0.38) | GRIK1GRIK2CPA1 | |
| SCHEMBL24215021 | 0.73 | GRIK1 (0.55) | GRIK1GRIK2CPA1 | |
| SCHEMBL7114024 | 0.73 | GRIK1 (0.55) | GRIK1GRIK2CPA1 | |
| SCHEMBL56402 | 0.73 | GRIK1 (0.55) | GRIK1GRIK2CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3155422-B2 | UNMASKING ENDOTOXINS IN SOLUTION | BIOMERIEUX DEUTSCHLAND GMBH (DE) | 2022-01-26 | — | — | EP | claimed |
| EP-0485500-B1 | AQUEOUS ANIONIC TENSIDE CONCENTRATES WITH OLEIC ACID SULPHONATES AS VISCOSITY CONTROLS | HENKEL KGAA (DE) | 1994-09-21 | — | — | EP | claimed |
| EP-3897134-A1 | STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS | Ecolab USA Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| US-20210299167-A1 | STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS | ECOLAB USA INC. | 2021-09-30 | — | — | US | disclosed |
| WO-2020118660-A1 | STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS | ECOLAB USA INC. (US) | 2020-06-18 | — | — | WO | disclosed |
| US-10039843-B2 | Paramagnetic solid lipid nanoparticles (pSLNs) containing metal amphiphilic complexes for MRI | BRACCO IMAGING S.P.A. (IT) | 2018-08-07 | — | — | US | disclosed |
| US-20170056307-A1 | EPROTIROME FOR USE IN THE PREVENTION AND/OR TREATMENT OF HAIR DISORDERS AND COMPOSITIONS THEREOF | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2017-03-02 | — | — | US | disclosed |
| US-20150258221-A1 | Paramagnetic Solid Lipid Nanoparticles (pSLNs) Containing Metal Amphiphilic Complexes For MRI | BRACCO IMAGING S.P.A. (IT) | 2015-09-17 | — | — | US | disclosed |
| US-20150182482-A1 | EPROTIROME FOR USE IN THE PREVENTION AND/OR TREATMENT OF HAIR DISORDERS AND COMPOSITIONS THEREOF | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2015-07-02 | — | — | US | disclosed |
| US-8778369-B2 | Barrier film-forming compositions and methods of use | DELAVAL HOLDING AB (SE) | 2014-07-15 | — | — | US | disclosed |
| US-20130261044-A1 | Cleaning Composition for Hard Surface | RHODIA OPERATIONS (FR) | 2013-10-03 | — | — | US | disclosed |
| US-4523921-A | FOR HAIR DYES | L'OREAL (FR) | 1985-06-18 | — | — | US | disclosed |
| EP-0137273-A2 | Silver halide color photographic light-sensitive material | KONICA CORPORATION (JP) | 1985-04-17 | — | — | EP | disclosed |
| US-4490356-A | Surface-active polysiloxanes | L'OREAL (FR) | 1984-12-25 | — | — | US | disclosed |
| US-4385138-A | Thermosetting powder resin based water-slurry coating composition | KANSAI PAINT CO., LTD. (JP) | 1983-05-24 | — | — | US | disclosed |
| US-4342742-A | FOR USE IN COSMETICS | L'OREAL (FR) | 1982-08-03 | — | — | US | disclosed |
| US-4250169-A | DIBEKACIN SULFATE, TRIGLYCERIDE, POLYOXYETHYLENE(20) CETYL ETHER | MEIJI SEIKA KAISHA LTD. (JP) | 1981-02-10 | — | — | US | disclosed |
| US-4230746-A | SULFATE FOAMING AGENT, TERTIARY AMINE OR QUATERNARY SALT DISPERSANT, SULFOSUCCINATE STABILIZER | GAF CORPORATION (US) | 1980-10-28 | — | — | US | disclosed |
| US-4208485-A | ORGANIC SULFATE, SULFOSUCCINIC ACID DERIVATIVES, AND AN ALKYLENEOXY AMINE | GAF CORPORATION (US) | 1980-06-17 | — | — | US | disclosed |
| US-4198316-A | Foaming composition for textile finishing and coatings | GAF CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150182482-A1 | EPROTIROME FOR USE IN THE PREVENTION AND/OR TREATMENT OF HAIR DISORDERS AND COMPOSITIONS THEREOF | PNMT, COXFA4L2, ERLIN1 | GRIK1 2661/4885GRIK2 3053/4885CPA1 2287/4885 |
| US-10039843-B2 | Paramagnetic solid lipid nanoparticles (pSLNs) containing metal amphiphilic complexes for MRI | PLIN3, PEX3, SLC39A3 | GRIK1 1234/4885GRIK2 840/4885CPA1 4585/4885 |
| US-20170056307-A1 | EPROTIROME FOR USE IN THE PREVENTION AND/OR TREATMENT OF HAIR DISORDERS AND COMPOSITIONS THEREOF | PNMT, COXFA4L2, ERLIN1 | GRIK1 2661/4885GRIK2 3053/4885CPA1 2287/4885 |
| US-20210299167-A1 | STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS | TPO, SPOP, LPO | GRIK1 904/4885GRIK2 1007/4885CPA1 3831/4885 |
| US-20150258221-A1 | Paramagnetic Solid Lipid Nanoparticles (pSLNs) Containing Metal Amphiphilic Complexes For MRI | PLIN3, PEX3, SLC39A3 | GRIK1 1234/4885GRIK2 840/4885CPA1 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.